Redhill Biopharma

$9.59
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.35 (-3.52%) As of 4:34 PM UTC today

Why Robinhood?

You can buy or sell RDHL and other stocks, options, and ETFs commission-free!

About RDHL

Redhill Biopharma Ltd. American Depositary Shares, also called Redhill Biopharma, is a biopharmaceutical company focusing on the development and commercialization of proprietary drugs for the treatment of gastrointestinal diseases. It operates through the Commercial Operations segment and the Research & Development segment. The Commercial Operations segment covers all areas relating to the commercial sales and operating expenses directly related to that activity and is being performed by the Company’s subsidiary in the United States. The Research & Development segment includes all activities related to the research and development of therapeutic candidates. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel. The listed name for RDHL is Redhill Biopharma Ltd. American Depositary Shares.

CEO
Dror Ben-Asher
Employees
—
Headquarters
Tel Aviv, Tel Aviv
Founded
2009
Market Cap
373.39M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
623.83K
High Today
$10.20
Low Today
$9.31
Open Price
$10.02
Volume
131.53K
52 Week High
$11.52
52 Week Low
$3.26

RDHL Earnings

-$0.38
-$0.24
-$0.11
$0.03
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 12, Pre-Market

You May Also Like

TBX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure